NewsRamp Editorial Team
NewsRamp
@newsramp
NewsRamp is a PR & Newswire Technology platform that enhances press release distribution by adapting content to align with how and where audiences consume information. Recognizing that most internet activity occurs outside of search, NewsRamp improves content discovery by programmatically curating press releases into multiple unique formats—news articles, blog posts, persona-based TLDRs, videos, audio, and Zero-Click content—and distributing this content through a network of news sites, blogs, forums, podcasts, video platforms, newsletters, and social media.
3808 articles
Articles
FAQ: Powermax Minerals' 2025 Atikokan REE Exploration Program Completion
What is the main announcement in this content? Powermax Minerals Inc. has completed its 2025 field exploration program at the Atikokan rare earth elements (REE) property in northwestern Ontario. What activities were included in the 2025 exploration program? The program encompassed geological mapping, prospecting, radiometri...
December 17, 2025Read more
FAQ: Brendan McKay's Recognition on Mortgage Professional America's Global 100 List
Who is Brendan McKay and what recognition did he receive? Brendan McKay is the Broker/Owner of McKay Mortgage Company and Chief Advocacy Officer of the Broker Action Coalition (BAC). He earned a place on Mortgage Professional America's prestigious 2025 Global 100 list, which recognizes the world's most impactful mortgage in...
December 17, 2025Read more
FAQ: Birchtech CEO's Outlook on 2025-2026 Performance and Water Treatment Growth
What is the main topic of this content? The content features an interview with Birchtech CEO Richard MacPherson discussing the company's third-quarter earnings results and its positive outlook for the remainder of 2025 and into 2026, with a focus on growth in the water treatment division. Why does Birchtech expect to finish...
December 17, 2025Read more
FAQ: Forward Industries' Solana-Focused Digital Asset Treasury Strategy and Buy Rating
What is the main topic of this content? The content focuses on Forward Industries Inc. (NASDAQ: FWDI) receiving a Buy rating and $10 price target from Oak Ridge Financial as the company transforms into the world's largest Solana-based Digital Asset Treasury (DAT). Why did Forward Industries receive a Buy rating? Oak Ridge F...
December 17, 2025Read more
FAQ: SotaTek's AI-Powered Merchant Onboarding Framework for Southeast Asian Digital Banks
What is the main topic of SotaTek's announcement? SotaTek announced a framework for using next-generation AI technologies, specifically agentic AI, voice AI, and intelligent workflow orchestration, to transform merchant onboarding for digital banks in Southeast Asia. Why is efficient merchant onboarding important for digita...
December 17, 2025Read more
FAQ: Soligenix's SGX302 Phase 2a Trial Results for Psoriasis Treatment
What is the main topic of this announcement? This announcement covers extended results from Soligenix's ongoing Phase 2a trial evaluating SGX302 (synthetic hypericin) topical gel formulation for treating mild-to-moderate psoriasis. What company is developing SGX302 and what type of company are they? Soligenix Inc. (NASDAQ: ...
December 17, 2025Read more
FAQ: CNS Pharmaceuticals Leadership Transition and Company Overview
What is the main announcement in this content? CNS Pharmaceuticals Inc. (NASDAQ: CNSP) has appointed Rami Levin, MBA, as President and Chief Executive Officer effective January 1, 2026, replacing John Climaco who has stepped down as CEO. Who is Rami Levin and what experience does he bring? Rami Levin brings nearly three dec...
December 17, 2025Read more
Graphite FAQ: Understanding Its Role in AI, Electric Mobility, and Advanced Materials
What is the main topic of this content? The content discusses how natural graphite, traditionally considered a commodity, is becoming a strategic engineering material that enables key technologies like artificial intelligence, electric mobility, and advanced materials. Why is graphite important for investors and industrial ...
December 17, 2025Read more
FAQ: Kairos Pharma's Clinical Trials Arena Award for ENV-105 in Advanced Prostate Cancer
What is the main news about Kairos Pharma Ltd.? Kairos Pharma Ltd. (NYSE American: KAPA) has been named a winner of the 2025 Clinical Trials Arena Excellence Awards, receiving the Research and Development Award for Advanced Prostate Cancer for its work on ENV-105. What is ENV-105 and what does it target? ENV-105 (carotuxima...
December 17, 2025Read more
FAQ: MAX Power Mining's $5 Million Private Placement with Vietnam-Based Strategic Partner
What is the main announcement in this content? MAX Power Mining has closed a non-brokered private placement for $5 million (CDN) with Vietnam-based Big Energy, an affiliate of Bitexco, forming a strategic partnership to accelerate natural hydrogen exploration in Saskatchewan. Why is this investment significant? This represe...
December 17, 2025Read more
FAQ: Trump's Push for AI in Health Care and Expert Caution
What is the main topic of this content? The content discusses President Trump's push to encourage states to adopt more AI technology in hospitals through federal funding, while experts call for caution about AI's role in healthcare. Why is this push for AI in healthcare significant? It represents a major government initiati...
December 17, 2025Read more
FAQ: Novel Biomarker USP22 and Immunotherapy Resistance
What is the main discovery reported in this content? Scientists at Northwestern Medicine have discovered a biological marker called USP22 that predicts which cancer patients are more resistant to immunotherapy. Why is this discovery significant? This discovery has the potential to transform care for cancer patients whose cu...
December 17, 2025Read more
FAQ: Oncotelic Therapeutics' Nanoparticle Drug Delivery Technology in Oncology
What is the main focus of Oncotelic Therapeutics' work described in this content? Oncotelic Therapeutics is applying nanoparticle technology to improve drug delivery in oncology, specifically using ultra-small carrier technologies to enhance existing cancer therapies through better bioavailability, precision targeting, and ...
December 17, 2025Read more
FAQ: Copper Hoarding in the US and Its Impact on Prices
What is the main topic of this content? The content discusses how copper hoarding in the United States could drive copper prices to unexpected highs, with prices already reaching record levels in 2025 and potentially continuing to rise into 2026. Why are copper prices expected to continue rising? Analysts forecast the coppe...
December 17, 2025Read more
FAQ: Xeriant's Corporate Communications Strategy and DUREVER™ Materials Technology
What is the main announcement in this content? Xeriant, Inc. (OTCQB: XERI) has engaged IBN (InvestorBrandNetwork) to support its corporate communications strategy through the InvestorWire platform. What type of company is Xeriant, Inc.? Xeriant is a technology company and strategic holding company focused on identifying, de...
December 17, 2025Read more
FAQ: Surging Tungsten Concentrate Demand and Almonty Industries' Perspective
What is the main topic of this content? The content discusses the surging global demand for tungsten concentrate, a scarce metal, as explained by Almonty Industries CEO Lewis Black in a Benzinga interview. Why is the current tungsten market situation significant? It's significant because tungsten prices in China have been h...
December 17, 2025Read more
FAQ: Lexston Mining Corporation's Advisory Board Appointment and Stock Option Grant
What is the main announcement in this news release? Lexston Mining Corporation announced two key developments: the appointment of Buddy Doyle to its newly established Advisory Board and the grant of 400,000 incentive stock options to certain directors, officers, and consultants. Who is Buddy Doyle and what experience does h...
December 17, 2025Read more
FAQ: GeoVax's GEO-MVA Vaccine Fill-Finish Completion and Phase 3 Trial Timeline
What is the main announcement from GeoVax Labs? GeoVax Labs announced the successful completion of fill-finish for the initial clinical batch of GEO-MVA, its next-generation Mpox/smallpox vaccine, with the product now entering final release evaluation before clinical use. What is GEO-MVA and what does it target? GEO-MVA is ...
December 17, 2025Read more
FAQ: Birchtech's Patent Infringement Award and Water Purification Expansion
What is Birchtech Corp. and what does it do? Birchtech Corp. (OTC: BCHT) is a clean technology company that operates through two subsidiaries: ME2C, focused on clean air technologies, and WE2C, dedicated to water purification. What is the main news about Birchtech in this article? Birchtech is expecting a significantly larg...
December 17, 2025Read more
FAQ: Critical Infrastructure Technologies and Aegis Critical Energy Defence Corp. Confidentiality Agreement
What is the main purpose of the agreement between CiTech and Aegis? The Non-Disclosure Agreement establishes a framework for the two companies to exchange confidential information and evaluate potential collaboration opportunities across secure energy, digital platforms, and critical infrastructure applications. What specif...
December 17, 2025Read more
FAQ: NeuroOne's Fiscal 2025 Financial Results and OneRF® System Milestones
What are the key financial highlights from NeuroOne's fiscal 2025 results? Product revenue grew 163% to $9.1 million for the full fiscal year and 907% to $2.7 million in Q4, while product gross margin increased significantly to 56.5% for the year and operating expenses decreased 4.6% to $12.4 million. What medical technolog...
December 17, 2025Read more